C.O. Truxton, inc. issues voluntary nationwide recall of Phenobarbital 15 mg Tablets, USP due to Labeling Error on Declared Strength

Posted by on April 24, 2017 11:39 pm
Tags:
Categories: US news

Festus iyorah – Fourth Estate Contributor

Bellmawr, NJ, United States (4E) – C.O. Truxton, Inc. is voluntarily recalling lot 70952A of Phenobarbital Tablets, USP, 15 mg, because a bottle labeled as phenobarbital 15 mg was found to contain phenobarbital 30 mg tablets.

This mislabeled product could expose the consumer or their pet(s) to potential overdosing that can cause severe intoxication which may lead to cardiogenic shock, renal failure, coma or death.

C.O. Truxton, Inc. has not received any reports of adverse events related to this recall.

The recalled product is indicated for use as a sedative or anticonvulsant and is packaged in 1000 count bottles, NDC 0463-6160-10, UPC 7 0463616010 6, lot number 70952A.

The 15 mg Tablet is debossed with “West-ward 445” on one side and blank on the reverse side; the 30 mg Tablet is debossed with “West-ward 450” on one side and scored on the reverse side.

The product was distributed Nationwide in the USA to Physician & Veterinarian Treatment Centers.

Consumers or distributors or retailers that have recalled product should stop using the product and return their product to their place of purchase.

C.O. Truxton, Inc. is notifying all customers on record who purchased the affected product via US Mail which includes a recall letter, recall response form and is arranging for full credit returns, replacements.

Consumers with questions regarding this recall can contact C.O Truxton, Inc. by phone at (856) 933-2333, Monday to Friday between the hours of 9am and 5pm (EST). Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

Article – All Rights Reserved.
Provided by FeedSyndicate

Comments